
Unlock deeper insights and drive smarter decision-making with clinically rich, research-ready RWD.
500k+ unique patients profiled across
60+ advanced/metastatic solid tumor types¹
*Others include head and neck, melanoma, SCLC, bladder, etc.
CRC, colorectal cancer; GEJ, gastroesophageal junction; NSCLC, non-small cell lung cancer; PFS, progression-free survival; SCLC, small cell lung cancer; RWD, real-world data.
A breadth and depth of complete patient-level data
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma GuardantINFORM™ for BioPharma